Analysis of concordance with antiemetic guidelines in pediatric, adolescent, and young adult patients with cancer using a large‐scale administrative database

The appropriate use of antiemetics is important for the prevention of chemotherapy‐induced nausea and vomiting (CINV); however, little is known about the rate of concordance with antiemetic guidelines for CINV in the field of pediatric, adolescent, and young adult.

• Publication year

  2019

• Venue

  Cancer Medicine

• Publication date

  2019-08-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/cam4.2486PMID 31469518PMCID 6797697
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of concordance with antiemetic guidelines in pediatric, adolescent, and young adult patients with cancer using a large‐scale administrative database

  2019cited by this paper
• Classification of the acute emetogenicity of chemotherapy in pediatric patients: A clinical practice guideline

  2019cited by this paper
• Adherence to pediatric acute chemotherapy‐induced nausea and vomiting guidelines in Canadian hospitals

  2018cited by this paper
• Cancer in adolescents and young adults: National incidence and characteristics in Japan.

  2017cited by this paper
• Guideline for the prevention of acute chemotherapy‐induced nausea and vomiting in pediatric cancer patients: A focused update

  2017cited by this paper
• Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update.

  2017cited by this paper
• Chemotherapy‐Induced Nausea and Vomiting Prophylaxis: Practice Within the Children's Oncology Group

  2016cited by this paper
• Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

  2016cited by this paper
• 2016 updated MASCC/ESMO consensus recommendations: Prevention of acute chemotherapy-induced nausea and vomiting in children

  2016cited by this paper
• Reducing Length of Hospital Stay Does Not Increase Readmission Rates in Early-Stage Gastric, Colon, and Lung Cancer Surgical Cases in Japanese Acute Care Hospitals

  2016cited by this paper
• Aprepitant and fosaprepitant: a 10-year review of efficacy and safety.

  2015cited by this paper
• Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summary

  2015cited by this paper
• Evaluation of Five Formulae for Estimating Body Surface Area of Nigerian Children

  2014cited by this paper
• Management of Chemotherapy-Induced Nausea and Vomiting

  2013cited by this paper
• Pattern of prophylaxis administration for chemotherapy-induced nausea and vomiting: an analysis of city-based health insurance data

  2013cited by this paper
• Association between corticosteroids and infection, sepsis, and infectious death in pediatric acute myeloid leukemia (AML): results from the Canadian infections in AML research group.

  2012cited by this paper
• Glucocorticoids augment survival and proliferation of tumor cells.

  2012cited by this paper
• Antiemetics: American Society of Clinical Oncology clinical practice guideline update.

  2011cited by this paper
• Adherence to ESMO clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting

  2010cited by this paper
• American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.

  2006cited by this paper
• Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy

  2005cited by this paper
• Changing patient perceptions of the side effects of cancer chemotherapy

  2002cited by this paper
• Dexamethasone-Induced Enhancement of Resistance to Ionizing Radiation and Chemotherapeutic Agents in Human Tumor Cells

  1999cited by this paper
• The effect of dexamethasone on the uptake of cisplatin in 9L glioma and the area of brain around tumor

  1998cited by this paper
• Chemotherapy of human malignant glioma

  1997cited by this paper

• Developing and assessing a vomiting-free ward workflow for gynecological patients receiving chemotherapy

  2025cites this paper
• Development and validation of the Pediatrics Functional Living Index—Emesis scale

  2025cites this paper
• Anti-Emetics in Children Receiving Chemotherapy for Solid Tumors and Leukemia: Pharmacology and Optimization of Therapy for Nausea and Vomiting

  2024cites this paper
• 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting

  2024cites this paper
• Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: the road to success.

  2024cites this paper
• 2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potential

  2023influential citation
• Postoperative mortality analysis on nationwide data from diagnosis procedure combination database in Japan

  2023cites this paper
• Postoperative mortality analysis of national Japanese Diagnosis Procedure Combination database with a focus on regional comparisons and changes over time

  2022cites this paper
• Chemotherapy-induced nausea and vomiting in children – the missing evidence

  2021cites this paper
• Adherence to guidelines for management of chemotherapy-induced nausea and vomiting in a tertiary public hospital

  2020cites this paper
• Analysis of concordance with antiemetic guidelines in pediatric, adolescent, and young adult patients with cancer using a large‐scale administrative database

  2019cites this paper